Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069430 · ClinicalTrials.gov registry record
A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I
A clinical trial of Anemia, Sickle Cell, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 44
- Enrollment target
- 1
- Study location
NCT03069430: Completed study of Anemia, Sickle Cell, sponsored by Medical University of South Carolina.
NCT03069430 is a study of Anemia, Sickle Cell that has completed, run by Medical University of South Carolina. The registered enrollment target is 44 participants, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03069430, a study of Anemia, Sickle Cell, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to test an intervention for children and adolescents ages 8-17 years with sickle cell disease and their families. In the first phase of this study, key informant interviews are being conducted with health care providers and children ages 8-17 with sickle cell disease and their primary caregivers. Participants are asked to review the intervention and provide feedback that will inform revision to the intervention.
Primary Outcome
Themes or categories developed from analysis of qualitative data on child/caregiver perceptions of the intervention.
Conditions Studied
Interventions
- BEHAVIORAL SELFY (Self Management for Youth with SCD)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2017-03-31 |
What the finished NCT03069430 record still lists
NCT03069430 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 1 intervention - of which SELFY (Self Management for Youth with SCD) is the first listed.
NCT03069430 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT03069430 about?
NCT03069430 is a clinical study titled "A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I". This study is being conducted to test an intervention for children and adolescents ages 8-17 years with sickle cell disease and their families. In the first phase of this study, key informant interviews are being conducted with health care providers and children ages 8-17 with sickle cell disease an...
What is the current status of trial NCT03069430?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2016-08-01. Estimated completion is 2017-03-31.
What conditions does trial NCT03069430 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
What interventions are being tested in trial NCT03069430?
The interventions under investigation include: SELFY (Self Management for Youth with SCD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03069430?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03069430 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03069430's enrollment target sits among peer trials
44 12th of 17 higher than 6 of 17 other Anemia, Sickle Cell trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Sickle Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
RECRUITING · Phase 2
-
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RECRUITING · Phase 1
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
A Blood Stem Cell Transplant for Sickle Cell Disease
ACTIVE NOT RECRUITING · Phase 1
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
-
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI